Lets Agree to Disagree on Operative vs Nonoperative Treatment for Distal Radius Fractures in the Elderly (LADON Radius)

NCT ID: NCT05631314

Last Updated: 2022-11-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

110 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-02-28

Study Completion Date

2026-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The primary objective of this study is to determine if non-operative treatment of distal radius fractures in patients aged 65 and over leads to equal funtional results as operative treatment. To do so patients will be included from two "schools" in which treatment i seither predominantly operative or non-operative. There will be no study intervention as patients will be treated as per local standard of care. The study is set up as an international multicenter study. Those patients included in the study will be follow-up at 6 weeks, 12 weeks, 1 year and 2 years after treatment was initiated. Our hypothesis is, that patients treated operatively will have better function than those treated non-operatively.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study is an international multicenter prospective observational cohort study for which patients will be identified after treatment has been initiated. Outcome data will be prospectively collected. Patients will be recruited from five hospitals in countries with a predominant preference for operative (Switzerland, "School" A) and non-operative treatment (the Netherlands, "School" B). After a treatment plan has been established, patients will be approached either during the index hospital admission or during one of their follow-up appointments in the outpatient clinic within six weeks to explain the purpose and procedures of the study. Patients will be asked to provide written informed consent. Following the identification of eligible patients, anonymous radiographs including key images of CT-scans if available and baseline characteristics (such as age, co-morbidities, activity level) as well as relevant laboratory results will be made available to the expert panel (details below) on a secure online platform. This will allow the members of the panel to reach a "clinical" decision regarding their treatment recommendation. The panel will be blinded to the actual treatment received and the origin of the case.

The expert panel will consist of three representatives from both "Schools". All panel members will be certified trauma surgeons from one of the participating hospitals. Eligible patients will be reviewed by the experts every two weeks. Patients will ultimately be included in the study if clinical equipoise is achieved, meaning the majority of experts in one "School", minimally two out of three, disagree with the received treatment in the other "School". For example, eligible patients would have received operative treatment based on the expert opinions in "School" A, however, were in fact treated non-operatively according to the treating surgeon in "School" B and vice versa. If the majority of the panel in one "School" agree with the received treatment in the other "School" the patient will be excluded. This will lead to two comparable groups for which true clinical equipoise exists. The actual treatment the patient receives, will continue as initially planned by the treating hospital.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Radius Fracture Distal

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

distal radius fracture elderly operative treatment natural experiment

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

operative treatment

This group will consist of patients who underwent operative treatment for a distal radius fracture.

operative treatment

Intervention Type PROCEDURE

Operative treatment can consist of open reduction and volar and/or dorsal plating or closed reduction and fixation with K-wires, external fixateur.

non-operative treatment

This group will consist of patients who underwent non-operative treatment for a distal radius fracture.

non-operative treatment

Intervention Type PROCEDURE

Non-operative treatment will consist of immobilization in a below the elbow cast for 4-6 weeks with or without prior closed reduction.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

operative treatment

Operative treatment can consist of open reduction and volar and/or dorsal plating or closed reduction and fixation with K-wires, external fixateur.

Intervention Type PROCEDURE

non-operative treatment

Non-operative treatment will consist of immobilization in a below the elbow cast for 4-6 weeks with or without prior closed reduction.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* ≥ 65 years old
* acute (\< 14 days after injury) distal radius fracture
* treated at one of the participating hospitals

Exclusion Criteria

* initial operative treatment at a non-participating hospital
* delayed presentation (\>14 days after injury)
* patient actively refuses the recommended treatment
* insufficient follow-up (\<12 months) or unavailable to follow-up due to residency in other hospital area
* concomitant injury to the ipsilateral or contralateral upper extremity
* cognitive impairment precluding answering questionnaires
* non-German, non-English, non-Dutch speaking
* pre-existing co-morbidities which preclude operative treatment
* pathological fractures
* open fractures
* neurovascular injury requiring operative treatment
Minimum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Arthrex GmbH

INDUSTRY

Sponsor Role collaborator

Luzerner Kantonsspital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Frank JP Beeres, PD PhD

Role: PRINCIPAL_INVESTIGATOR

Luzerner Kantonsspital

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Nicole M van Veelen, MD

Role: CONTACT

Phone: 041412051959

Email: [email protected]

Frank JP Beeres, PD PhD

Role: CONTACT

Phone: +41412051914

Email: [email protected]

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

LADON radius

Identifier Type: -

Identifier Source: org_study_id